She said yes! Ergomed Supports Patient’s Honeymoon Trial

Discover how Ergomed’s orphan drug team ensured a newly-enrolled Wilson’s Disease patient could participate in a Phase II/III Study while celebrating her honeymoon.

 
With weekly safety lab tests required during this critical period, Ergomed coordinated with a clinic in Cyprus to provide seamless, local blood-draws and ongoing monitoring, allowing her to continue the trial safely. Download the full case study to see how Ergomed’s patient-centered approach and flexible solutions support rare disease trials, empowering patients to live fully while participating in essential research.  

Please fill out the form to view the content

"*" indicates required fields

Please enter your details to get access to the resource

By submitting this form, you consent to your personal data submitted in the form being processed in alignment with our Online Privacy and Cookies policy. Your personal data will be processed to facilitate your request and may be used for sending you additional marketing and business development-related information about Ergomed, its affiliates, and our services. You can withdraw your consent anytime by messaging marketing@ergomedgroup.com, and we will promptly remove your data from our records. For more information about how we will process your personal data and your rights, please see our Online Privacy and Cookies policy.
This field is for validation purposes and should be left unchanged.